We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+26.38%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$140B
AUM Growth
+$23.9B
(+21%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
16.71%
Holding
4,310
New
356
Increased
1,988
Reduced
1,282
Closed
383
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Amazon
AMZN
|
+$922M |
| 3 |
Apple
AAPL
|
+$920M |
| 4 |
Otis Worldwide
OTIS
|
+$525M |
| 5 |
Trip.com Group
TCOM
|
+$523M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.9B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$942M |
| 3 |
Linde
LIN
|
+$582M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$392M |
| 5 |
McKesson
MCK
|
+$322M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.27% |
| 2 | Healthcare | 11.06% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CZZ
1651
DELISTED
Cosan Limited
CZZ
| $5.28M | ﹤0.01% |
350,624
+338,349
| +2,756% | +$4.43M |
|
|
GBT
1652
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.27M | ﹤0.01% |
83,402
+25,784
| +45% | +$1.77M |
|
|
ADAM
1653
Adamas Trust
ADAM
$848M
| $5.26M | ﹤0.01% |
504,198
+343,453
| +214% | +$3.01M |
|
1654
Murphy Oil
MUR
$5.17B
| $5.25M | ﹤0.01% |
380,519
-100,973
| -21% | -$1.16M |
|
|
K
1655
CALL
DELISTED
Kellanova
K
| $5.23M | ﹤0.01% |
84,348
+6,070
| +8% | +$367K |
|
1656
Texas Roadhouse
TXRH
$13.7B
| $5.23M | ﹤0.01% |
99,462
+49,470
| +99% | +$2.41M |
|
1657
YPF
YPF
$19.1B
| $5.22M | ﹤0.01% |
908,265
-73,528
| -7% | -$343K |
|
1658
AstraZeneca
AZN
$250B
| $5.22M | ﹤0.01% |
+49,325
| New | +$5.09M |
|
1659
Allogene Therapeutics
ALLO
$673M
| $5.21M | ﹤0.01% |
121,612
+47,806
| +65% | +$1.73M |
|
|
SNV
1660
DELISTED
Synovus
SNV
| $5.2M | ﹤0.01% |
253,317
+85,947
| +51% | +$1.66M |
|
1661
PUT
American Electric Power
AEP
$68.8B
| $5.18M | ﹤0.01% |
65,000
| – | – |
|
1662
CALL
Ferrari
RACE
$71.5B
| $5.13M | ﹤0.01% |
30,000
| – | – |
|
1663
First Trust Securitized Plus ETF
DEED
$64.4M
| $5.12M | ﹤0.01% |
+200,000
| New | +$5.08M |
|
1664
Tronox
TROX
$933M
| $5.1M | ﹤0.01% |
706,098
-236,141
| -25% | -$1.56M |
|
1665
CALL
Valero Energy
VLO
$87.1B
| $5.09M | ﹤0.01% |
86,600
| – | – |
|
|
TPH
1666
DELISTED
Tri Pointe Homes
TPH
| $5.09M | ﹤0.01% |
346,313
+155,625
| +82% | +$1.91M |
|
|
TERP
1667
DELISTED
TerraForm Power, Inc
TERP
| $5.08M | ﹤0.01% |
275,290
-42,527
| -13% | -$752K |
|
|
IAA
1668
DELISTED
IAA, Inc. Common Stock
IAA
| $5.07M | ﹤0.01% |
131,478
+16,032
| +14% | +$598K |
|
1669
American Eagle Outfitters
AEO
$2.99B
| $5.07M | ﹤0.01% |
464,806
+283,210
| +156% | +$2.68M |
|
1670
Polaris
PII
$4.16B
| $5.06M | ﹤0.01% |
54,652
-41,921
| -43% | -$3.19M |
|
1671
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $5.04M | ﹤0.01% |
163,106
+43,700
| +37% | +$1.23M |
|
|
NATI
1672
DELISTED
National Instruments Corp
NATI
| $5.04M | ﹤0.01% |
130,199
+19,672
| +18% | +$744K |
|
1673
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
| $5.03M | ﹤0.01% |
169,300
+133,100
| +368% | +$3.67M |
|
1674
Helen of Troy
HELE
$689M
| $5.02M | ﹤0.01% |
26,640
+5,468
| +26% | +$895K |
|
|
ZNGA
1675
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $5.01M | ﹤0.01% |
525,000
-10,600
| -2% | -$86.9K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2020 Portfolio in Review
As of Q2 2020, Credit Suisse held 4,310 positions worth $140B, up 21% from $116B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2020 filing shows 356 new, 1,988 increased, 1,282 reduced and 383 closed positions. Its largest new stake was Otis Worldwide: 10,131,011 shares worth $576M. The largest sale was Allergan plc, an estimated $1.9B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Credit Suisse's largest Q2 2020 buy was Otis Worldwide: 10,131,011 shares worth $576M.
- Credit Suisse added most to Microsoft in Q2 2020, an estimated $1.02B increase.
- Credit Suisse's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $942M.
- Credit Suisse fully exited Allergan plc in Q2 2020, selling an estimated $1.9B.
- Credit Suisse's ten largest holdings make up 17% of its $140B portfolio in Q2 2020.
- Credit Suisse opened 356 new positions and closed 383 in Q2 2020.
- Credit Suisse's portfolio value rose 21% quarter-over-quarter to $140B.
Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.